Salofalk rectal suspension 4g/60g, enema 60g 7pcs — Made in Germany — Free Delivery

Rectal suspension Salofalk is indicated for the treatment of exacerbations of ulcerative colitis.

Active substance: mesalazine;

1 enema (60 g of suspension) contains 4.0 g of mesalazine (5-aminosalicylic acid);

Excipients: sodium benzoate (E 211), potassium metabisulfite (E 224), Trilon B, carbomer 934 R [carbopol 974 R], potassium acetate, xanthan gum, purified water.

Hypersensitivity to mesalazine, to any of the components of the preparation or to salicylates, gastric ulcer and duodenal ulcer in the acute stage, severe hepatic and / or renal failure, hemorrhagic diathesis.

Patients with symptoms of acute inflammation are recommended to use the contents of one enema (60 g of suspension) rectally 1 time per day in the evening, before bedtime.

The best result is achieved if the intestines are cleaned before using the Salofalk enema.

The desired therapeutic result can be achieved only with the regular and constant use of Salofalk enemas.

The duration of use is determined by the doctor.

Should be taken during pregnancy only when the expected benefit outweighs the potential risk.

In cases where dizziness is observed during treatment, you should refrain from driving and working with mechanisms.

There are data on cases of overdose (for example, willful committing suicide with a high oral dose of mesalazine), do not indicate renal or hepatic toxicity. To date, no cases of intoxication and specific antidotes have been reported. There is no specific antidote; treatment should be symptomatic and supportive. If necessary, electrolyte infusion (forced diuresis) is used.

Adverse reactions most often observed in clinical studies: diarrhea, nausea, stomach pain, headache, vomiting and rash. Hypersensitivity reactions have sometimes developed.

Special studies of preparation interactions have not been conducted.

Does not require special storage conditions.

Keep out of the reach of children.

Shelf life is 2 years.